(Q53116048)

English

A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer.

scientific article published on 12 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Andrew M Baschnagel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Peter Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Gregory Gustafson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Ishmael Jaiyesmi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Mitchell Folbe

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Hong Ye

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Jan Akervall

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Daniel Krauss

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

12 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

240-246

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

https://scigraph.springernature.com/pub.10.1007/s10147-013-0540-y

0 references

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

State-of-the-art management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN).

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0540-Y

21 January 2018

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23479120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23479120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23479120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23479120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent Cisplatin and Radiation Versus Cetuximab and Radiation for Locally Advanced Head-and-Neck Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23479120

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-013-0540-Y

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23479120%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53116048&oldid=1418051313"